Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial. (2016)

First Author: Hale MD
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.12723

PubMed Identifier: 27769054

Publication URI: http://europepmc.org/abstract/MED/27769054

Type: Journal Article/Review

Volume: 7

Parent Publication: Oncotarget

Issue: 47

ISSN: 1949-2553